AI Insights: AI Tumor Segmentation When Contrast Isn't an Option

AI-based tumor segmentation technology for MRI studies demonstrates clinical promise in cases where contrast administration is contraindicated or unavailable. This advancement represents important progress in medical imaging AI applications and clinical decision support.